MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Progression of cortical thinning in Parkinson’s disease

    A. Vo, C. Tremblay, S. Rahayel, Y. Yau, A. Dagher (Montréal, QC, Canada)

    Objective: We sought to validate cortical thickness as an objective biomarker of Parkinson’s disease (PD) progression. Background: Cortical thickness analysis has been proposed as a…
  • MDS Virtual Congress 2020

    Asymmetrical cochlear dysfunction as a lateralized non-motor feature in Parkinson’s disease

    R. Cerroni, A. Viziano, R. Sisto, A. Moleti, N.B Mercuri, A. Stefani, M. Pierantozzi (Rome, Italy)

    Objective: We evaluated hearing function in a population of PD patients to investigate: 1) the occurrence of hearing loss; 2) the possible lateralization of hearing…
  • MDS Virtual Congress 2020

    Wearable sensors- early prediction of freezing of gait episodes based on bilateral leg stepping coherence in patients with Parkinson’s disease

    T. Krasovsky, M. Plotnik (Haifa, Israel)

    Objective: To evaluate the characteristics of a freezing of gait (FOG) detection algorithm based on continuous data from inertial sensors (placed bilaterally on the shanks…
  • MDS Virtual Congress 2020

    Excessive Daytime Sleepiness in Parkinson’s disease and Narcolepsy Genetic Risk Allele HLA DQB1*0602

    S. Azher, E. Molho, A. Hahn, O. Adam (Albany, NY, USA)

    Objective: To determine whether narcolepsy risk allele HLA DQB1*0602 is associated with excessive daytime sleepiness (EDS) in patients with Parkinson's disease (PD) on dopaminergic agents.…
  • MDS Virtual Congress 2020

    Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment patients with Parkinson’s disease

    H. Zheng, D. Huang, C. Xu, Y. sun (Nanjing, China)

    Objective: Due to the high prevalence of mild cognitive impairment (MCI) in Parkinson disease (PD), routine cognitive screening is important for the optimal management of…
  • MDS Virtual Congress 2020

    Effect of regular practice of yoga versus aerobic exercise on motor and non motor signs and motor cortex plasticity in Parkinson’s disease

    A. Kishore, P. James, A. Thejaus, S. Krishnan, K. Divya, S. Meunier (Trivandrum, India)

    Objective: To test whether the regular practice of yoga (1) improves motor and non-motor symptoms and signs in Parkinson’s disease (PD) more than aerobic training…
  • MDS Virtual Congress 2020

    Depression in various forms of parkinsonism and striatal hyperkinesis

    R. Matmurodov, K.h Khalimova, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To examine of the degree of depression in various forms of Parkinsonism and striatal hyperkinesis Background: Depression is the basis of affective disorders. Almost…
  • MDS Virtual Congress 2020

    CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients

    E. Olivola, M. Stampanoni Bassi, L. Gilio, C. Femiano, G. Ricciardo Rizzo, F. Sica, L. Belli, R. Furlan, A. Finardi, D. Centonze, N. Modugno (Pozzilli, Italy)

    Objective: The aims of the present study were to investigate the levels of inflammatory cytokines in the cerebrospinal fluid (CSF) of drug-naïve Parkinson's Disease (PD)…
  • MDS Virtual Congress 2020

    Intestinal Methanogen Overgrowth (IMO) More Prevalent than SIBO in Parkinson’s disease with Constipation: Preliminary Results

    A. Sharma, Y. Yan, T. Karunaratne, A. Eubanks, J. Kurek, J. Morgan, S. Rao (Augusta, GA, USA)

    Objective: Our aim is to quantify the prevalence of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) in PD subjects with constipation compared…
  • MDS Virtual Congress 2020

    Urinary Symptoms and Parkinson’s Disease: The Patient’s Perspective

    J. Wertheimer, B. Reynolds, C. Walton, J. McNamara, T. Hamran, S. Freedland (Los Angeles, CA, USA)

    Objective: To learn about prevalence rates and the impact of urinary symptoms on day-to-day function and quality of life from the patient’s perspective. Background: Urinary…
  • « Previous Page
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • 149
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley